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For a variety of ligand states, adenylate cyclase activity in the presence of Mn’+ was greater than with 
Mg2+. Trypsin treatment of intact hepatocytes, under conditions which destroy cell surface glucagon 
receptors, led to a first order loss of glucagon-stimulated adenylate cyclase activity in isolated membranes 
assayed in the presence of Mn2+ whether or not GTP (100 PM) was present in the assays. Arrhenius plots 
of basal activity exhibited a break at around 22’C, those with NaF were linear and those with glucagon f 
GTP (100 PM) were biphasic with a break at around 28OC. It is suggested that Mn2+ perturbs the coupling 
interaction between the glucagon receptor and catalytic unit of adenylate cyclase at the level of the guanine 
nucleotide regulatory protein. This appears to take the form of Mn2+ preventing GTP from initiating 
glucagon’s activation of adenylate cyclase through a collision coupling mechanism. 
Adenylate cyclase Glucagon Mn2’ Guanine nucleotide Receptor coupling 
1. INTRODUCTION 
Adenylate cyclase catalyses the conversion of 
ATP to cyclic AMP. This reaction is usually taken 
to use Mg ‘+ both as a co-substrate with ATP and , 
also as a regulator, binding to a distinct divalent 
cation site [l-8]. Recently, there has been con- 
siderable interest expressed in the very different ef- 
fects exerted when Mn2+ replaces Mg2+ in the 
assay for adenylate cyclase. 
[ 12,15,16] and neurohypophyseal hormone [ 171 is 
achieved via productive collisions, within the plane 
of the membrane, between these various com- 
ponents. In liver, 3 independent methods (receptor 
depletion [14]; Arrhenius plot analysis [14]; ir- 
radiation inactivation [ 13]), have been used to sup- 
port this contention. 
Hormone-stimulated adenylate cyclases consist 
of at least 3 distinct components: a catalytic unit 
responsible for cyclic AMP production; a receptor 
specific for a particular hormone; and one or more 
guanine nucleotide regulatory components. The 
guanine nucleotide regulatory proteins appear to 
regulate the coupling interaction between the 
receptor and catalytic unit [9-121. There is now 
considerable evidence consistent with the 
hypothesis that hormonal activation of adenylate 
cyclase by glucagon [ 11,13,14], &agonists 
Here, we examine the effect of replacing Mg2+ 
with Mn2+, in the adenylate cyclase assay, on the 
activity of the enzyme in liver plasma membranes 
and its mode of coupling to the glucagon receptor. 
2. MATERIALS AND METHODS 
Glucagon was a kind gift from Dr W. W. Bromer 
of Eli Lilly and Co (Indianapolis IN). 
Phosphocreatine, creatine phosphokinase, trypsin 
(type II from bovine pancreas) and trypsin in- 
hibitor (type 1-S from soya bean) were from Sigma 
(St Louis MO). Cyclic AMP, ATP, GTP (Na salt), 
Published by Elsevier Science Publishers B. V. 
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p[NH]ppG (guanosine 5 ’ -[ay-imido]triphos- 
phate), triethanolamine-HCl and collagenase were 
from Boehringer (Mannheim). All other chemicals 
were of AR quality from BDH Chemicals 
(London). 
Adenylate cyclase was assayed in a cocktail at 
pH 7.4 containing final concentrations of 25 mM 
triethanolamine-HCl, 1 mM EDTA, 1 mM 
theophylline, 1.5 mM ATP and an ATP- 
regenerating system of 7.4 mg creatine 
phosphate/ml and 1 mg creatine kinase/ml. These 
contained either 5 mM MgS04 or the stated con- 
centration of MnS04. When MnS04 was used it 
was added to the reaction mixture immediately 
prior to initiating the reaction with membranes. 
Cyclic AMP produced was determined as in [18]. 
In all cases, initial rates were taken from linear 
timecourses of cyclic AMP production at 30°C. 
Arrhenius plots were constructed and data analys- 
ed by a fitting procedure detailed in [ 191. Linearity 
of cyclic AMP production was ensured over the en- 
tire temperature range examined. 
Plasma membranes were purified from male 
Sprague-Dawley rats as in [18,20]. Hepatocytes 
were also prepared from such animals and shown 
to be intact and viable [14]. As described in [14], 
cells were pre-incubated before treatment with 
trypsin (0.2 mg/ml) and incubated at 37°C. At ap- 
propriate time intervals samples were taken and 
quenched by immediate mixing with ice-cold stop- 
ping buffer containing excess trypsin inhibitor 
(details in [14]). The cells were then broken and a 
membrane fraction prepared for assay [14,21]. 
Protein was determined by a modified 
microbiuret method [ 191. 
3. RESULTS 
In the absence of either Mn2+ or Mg2+ there was 
no observable adenylate cyclase activity, irrespec- 
tive of the stimulating ligand employed. However, 
low [Mr?] led to the expression of ligand- 
stimulated adenylate cyclase activity with half- 
maximal activations occurring at around l-2 mM 
Mn*+ under the assay conditions employed. 
[Mn”] at > 10 mM led to a decrease in the 
adenylate cyclase activity. This is similar to that 
reported in [6,7]. For the rest of this study we 
employed 5 mM Mn*+ in all assays where Mn*+ 
was to be added. Table 1 compares the specific ac- 
tivities and degree of activation elicited by various 
ligands when either Mg*+ or Mn*+ was added to 
assays. 
Intact hepatocytes were incubated with trypsin 
(see [14]) for various time intervals at 37°C before 
quenching the reaction with ice-cold trypsin in- 
hibitor and assay of adenylate cyclase in a broken 
membrane fraction prepared from these cells. In 
[14], we demonstrated that under these conditions 
trypsin does not cause cell breakage and merely 
acts on the external surface of the cell plasma 
membrane. There was no loss of basal, fluoride- or 
guanine-nucleotide-stimulated activity but there 
was a first-order loss of glucagon receptors [ 141. In 
agreement with our studies using Mg*+ (5 mM) in 
adenylate cyclase assays, we observed a first-order 
loss of glucagon-stimulated adenylate cyclase ac- 
tivity. The loss of glucagon + GTP (100 PM)- 
stimulated activity was markedly non-linear 
(fig.1). However, if Mn*+ (5 mM) replaced Mg*+ 
in these assays then there was apparently a simple 
Table 1 
Adenylate cyclase activity in hepatocyte membranes 
Mg2+ Mn2+ 
pmol. mint. mg protein-’ 
(-fold stimulation over basal) 
Ratio of 
activities: 
Mn2+/Mg2+ 
Basal 0.74 * 0.25 (x 1 ) 3.95 f 0.43 (x 1 ) 5.3 
GTP (1OOpM) 1.48 f 0.21 (x 2 ) 3.29 + 0.38 (x0.8) 2.2 
NaF (15 mM) 7.70 f 0.31 (x 10.4) 21.6 I!I 3.3 (x5.5) 2.8 
Glucagon (1 PM) 11.1 f 1.1 (x15 ) 14.9 + 1.5 (x3.8) 1.3 
Glucagon + GTP 15.7 * 0.5 (x21 ) 30.0 f 0.6 (x7.6) 1.9 
Assays were all carried out at 30°C for 10 min (see [18]); errors are SD; n = 3 
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Fig. 1. Glucagon-stimulate adenylate cyclase activity in 
trypsin-treated hepatocytes. Assays were carried out on 
glucagon (10e6 M)-stimulated (0, 0) and glucagon + 
GTP (100 pM)-stimulated (0, H) adenylate cyclase 
activity in either the presence of 5 mM Mg2+ (a,O) or 
5 mM Mn2+ (m, 0). As detailed in 1141, intact 
hepatocytes were treated for various time intervals with 
trypsin at 37°C. The reaction was terminated by adding 
excess trypsin inhibitor and cooling on ice. A membrane 
fraction was then assayed. As found in 114) there was no 
loss in basal, NaF or p[NH]ppG-stimulated adenylate 
cyclase activities over this entire period. Furthermore, 
receptor loss as followed by specific ‘251-glucagon 
binding occurred exponentially with a half-life that 
corresponded to that observed for the glucagon- 
stimulated adenylate cyclase activity, in the absence of 
added GTP and with Mg2’ (see [14]). This experiment 
shows data from a typical experiment repeated with 3 
different cell preparations. In each case assays were 
performed with Mg2+ as well as with Mn2* so as to act 
as an internal control [ 141. 
first-order loss of glucagon-stimulated activity 
whether or not GTP (IOOpM) was present (fig.1). 
Table 2 summarizes the forms of the Arrhenius 
plots for the various ligand-stimulated states of 
adenylate cyclase, when Mn2+ (5 mM) was present 
in the assays. These-bear comparison with those we 
obtained using Mg2+ (5 mM) in the assays with two 
exceptions: the basal and glucagon + GTP 
(100 EM)-stimulated states (fig.2). Arrhenius plots 
of basal adenylate cyclase activity were biphasic 
with a break occurring at around 22°C (fig.2) 
when Mn2+ was used. A break at this temperature 
occurs with Mg” too, although in that case activa- 
tion energies were lower above the break than 
below [22]. The converse appears to be true for 
Mn2” (fig.2). In the case of the glucagon + GTP 
@8* 
3-1 3.2 3.3 34 3.5 3.6 ~l~/T’K) 
Fig.2. Arrhenius plots of adenylate cyclase activity in rat 
liver plasma membranes. Adenylate cyclase assays were 
carried out in the presence of low6 M glucagon (I), 
glucagon + 100 FM GTP (m) and under basal conditions 
(0) in the presence of 5 mM Mn2+. Purified rat liver 
plasma membranes were used 118) and linearity of cyclic 
AMP production was observed at all temperatures. Data 
were treated as in [19]. This shows a typical result. 
(100 PM)-stimulated state, Arrhenius plots of this 
activity are clearly linear when MgZf was in the 
assay [14]. However, if Mn2+ replaced Mg2+, then 
a biphasic plot resulted with a well-defined break 
at around 28°C (fig.3). In the absence of added 
GTP (100 FM), Arrhenius plots of glucagon- 
stimulated activity were biphasic, exhibiting a 
break at around 28°C with either Mn2+ (fig.2) or 
Mg2+ [14,18,22] in the assays. 
4. DISCUSSION 
As has been shown for a variety of adenylate 
cyclase systems [6,7,10], Mn2+ yields a basal 
adenylate cyclase activity that is profoundly 
greater than that observed with Mg2+ (table 1). We 
observed that in the presence of Mn2+ (5 mM) a 
variety of ligands, including glucagon are still able 
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to elicit activation of the enzyme. However, the 
degree of stimulation of activity, over that of 
basal, was severely reduced. In each case the 
specific activity expressed in the presence of Mn2+ 
was around 2-fold higher than when Mg2i was us- 
ed (table 1). This effect was magnified, however, in 
the basal condition which was some 5-fold higher 
with Mn2+ (table 1). 
We 1141, and others 1131, have suggested that 
glucagon, in the presence of exogenous GTP 
(lOO/cM) can activate adenylate cyclase through a 
collision coupling mechanism as proposed in [ 151 
for the P-agonist activation of turkey erythrocyte 
adenylate cyclase. This mechanism bears analogy 
with those proposed by others for P-agonist [12] 
and neurohypophyseal hormone [ 171 activation of 
adenylate cyclase. Such a mechanism allows for 
multiple catalytic units to be activated by a single 
occupied receptor. Hence, under these conditions, 
hormone-stimulated activity is relatively insen- 
sitive to receptor loss [14]. In contrast, the addition 
of glucagon alone appears to promote a mobile 
receptor mechanism of coupling [13,14,23]. Here, 
the receptor is presumed to form a ~ransmembrane 
complex with an activated catalytic unit and 
regulatory protein (see [14]). In the absence of 
stimulating hormone, both of these mechanisms 
assume that the receptor, guanine nucleotide 
coupling protein and catalytic unit of adenylate 
cyclase migrate as independent entities in the plane 
of the bilayer. Only in the presence of hormone do 
they interact physically to elicit activation of 
adenylate cyclase. The basic difference in these 
mechanisms is that under conditions where activa- 
tion via a mobile receptor model occurs, then these 
3 interacting entities form a stable, activated, 
transmembrane complex, However, when activa- 
tion occurs via a collision coupling mechanism, 
this complex breaks down to release a transiently 
activated catalytic unit [ 13- 15,231. 
Under conditions where a mobile receptor 
mechanism is obeyed, the selective depletion of 
glucagon receptors, achieved by trypsin treatment 
of intact hepatocytes, causes a proportional loss in 
the glucagon-stimulated adenylate cyclase activity 
of membranes derived from these cells [ 141. Using 
such a procedure we observed identical first-order 
kinetics for loss of both glucagon binding and 
glucagon-stimulated adenylate cyclase activity 
[14]. However, by merely raising the GTP concen- 
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trations in such assays a remarkably different 
result was apparent. In this instance the glucagon 
(+ GTP)-stimulated activity was markedly insen- 
sitive to receptor loss [14] and the decay kinetics 
were distinctly non-linear (1141, fig. 1). This is 
precisely what is expected for a collision coupling 
mechanism [151 where one occupied receptor leads 
to the production of a number of activated 
catalytic units. 
In marked contrast to these observations, carry- 
ing out identical experiments, but just replacing 
Mg2+ in the assays with Mn2+, we observed no ef- 
fect of GTP on the sensitivity of glucagon- 
stimulated adenylate cyclase to receptor loss 
(fig. 1). In both instances decay curves were clearly 
first-order and paralleled the loss in activity 
observed for glucagon-stimulated adenylate 
cyclase activity in the presence of Mg2+ (fig: 1) im- 
plying that a mobile receptor mechanism was being 
obeyed. GTP, however, still exerts an activating 
effect on the glucagon-stimulated activity in the 
presence of Mn2+ (table 1). We suggest hen, that 
Mn2+ perturbs the coupling between the receptor 
and catalytic unit, such as to prevent glucagon- 
activating adenylate cyclase through a collision 
coupling mechanism at elevated GTP 
concentrations. 
To gain support for this contention, we analysed 
Arrhenius plots of various states of the enzyme 
with Mn2+ present in the assays. We have 
presented considerable evidence, based upon a 
variety of techniques (detailed in [ 14,22,24,25]), 
which is consistent with the notion that the liver 
plasma membrane xhibits a lipid phase separation 
occurring at around 28°C in the external half of 
the bilayer, whereas no such lipid phase separation 
occurs in the inner half of the bilayer. Both the 
guanine nucleotide regulatory protein (NJ and 
catalytic unit of adenylate cyclase have limited 
hydrophobic surfaces f10,261 and are considered to 
have their functional globular regions restricted to 
the inner half of the bilayer [22,24,25]. Thus Ar- 
rhenius plots of NaF- or guanine nucleotide- 
stimulated activity are linear as they do not sense 
the lipid phase separation occurring in the external 
half of the bilayer. In contrast, under conditions 
where a mobile receptor mechanism is obeyed then 
we would expect the transmembrane complex 
formed with the glucagon receptor to experience 
the lipid environment of the external half of the 
Volume 155, number 2 FEBS LETTERS 
Table 2 
Arrhenius plots of ride&ate &y&se activity 
May 1983 
Ligand Form of plot Break point 
(Tt “C) 
Activation energy (kJ . mol-‘) 
T> T, T< T, 
Basal Biphasic 21,8 f 0.4 62.6 + 1.4 22.3 it 4.2 
GTP Linear 51.9 + 3.4 
Fluoride Linear 45.2 2 12.3 
Gfucagon Biphasic 27.7 f 2.6 20.4 -4 6.3 38.7 rt 2.9 
Gfucagon + GTP Biphasic 28.8 rt: 1.5 46.0 + 3.9 75.1 i: 16.1 
In all instances assays contained 5 mM Mn2* rather than Mg 2+ Data were obtained over 2-42°C with determinations , 
made at between 30-35 different temperatures. Data were analysed and break points determined by a least squares 
minimal~sati~~ procedure from [19f. AIf pIots were carried out with 3 preparations and the figures shown are + SD 
bilayer. Under these conditions it does and Ar- 
rhenius plots exhibit a well-defined break at 
around 28°C when glucagon is added without high 
exogenous [GTP] 114,18]+ However, under colli- 
sion coupling conditions the steady state activity of 
adenylate cyclase is expressed by activated catalytic 
units which are not associated with the receptor. 
Thus Arrhenius plots of glucagon-stimulated 
adenylate cyclase in the presence of high GTP con- 
centrations are linear [14]* However, if Mn2’ 
replaced Mg2+ in these assays, then Arrheni~s 
plots of the glu~agon-stimulated activity were 
biphasic, exhibiting a well-defined break at around 
28”C, irrespective of whetter or not GTP was add- 
ed to the assays (fig.2; table 2). These data suggest 
that, under both conditions, a transmembrane 
complex is formed with the receptor, and 
regulatory protein, conve~ng sensitivity to the 
lipid phase separation, in the external half of the 
bilayer, upon the catalytic unit. This supports our 
contention that, unlike with Mg2+, Mn*’ prevents 
glucagon activating the enzyme via a collision 
coupling mechanism at elevated [GTPJ. 
fn a number of systems Mnzc has been shown to 
exert potent effects on adenylate cyclase at the 
level of guanine nucleotide regulation [1,3,5-71. It 
has even been suggested that the guanine 
nucleotide regulatory protein exhibits a distinct, 
divalent cation, regulatory site to which free 
Mn*VMg’* can bind !6]. Mn2” appears to be able 
to uncouple ACTH- f3] and P-agonist f6,27] 
stimulated adenylate cyclase. Indeed, at low con- 
centrations it has been shown to selectively uncou- 
ple regulation of adenylate cyclase by inhibitory 
hormones [S]. These studies appear to support our 
observations of a perturbation at the level of 
coupling mediated by guanine nucleotides. 
Mn”, however, also altered the form of the 
basal Arrhenius plot (fig.3) from that observed us- 
ing Mg2+ 1221. Arrhenius plots of basal adenylate 
cyclase activity exhibit a break at around 20-22°C 
in liver and other systems (see [22,28]). This is ap- 
parently a protein-mediated event rather than be- 
ing due to the lipid environment of the enzyme 
[22,28]. Here we show that for basal activity Mn2’ 
yielded a plot with activation energies which were 
greater above the break than below (fig.3) whereas 
the converse was due when Mg2+ 1221 replaced 
Mn2’ in the assay. The ground state enzyme may 
exist in two states [29]. Presumably, the biphasic 
nature of the Arrhenius plot reflects the 
equilibrium between these two states and the rather 
different activation energies expressed in each 
case. Mn2+, acting either on the guanine- 
nucleotide regulatory protein or directly on the 
catalytic unit, might then alter the nonformation of 
the enzyme such that at %2W’C an activated en- 
zyme exhibiting a high activation energy 
predominates. Indeed, observations that the 
solubilized enzyme [Z] and the enzyme from cyc- 
cells, which lack a stimulatory gua~ine-nucleotide 
regulatory protein [lo], exhibit activity with Mn” 
but very little with Mg2+, might suggest hat Mn2+ 
can alter the conformation and hence activity state 
of the enzyme. 
Clearly Mn2’ exerts potent effects on adenylate 
cyclase and is a useful tool for probing the regula- 
tion of this enzyme by guanine-nu~leotide 
regulatory protein. 
315 
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